T-Cell Vaccination in Multiple Sclerosis (MS)

Clinical trial NCT00220428 · UNKNOWN

Trial details

NCT number: NCT00220428
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 1998-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.